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Abstract	  
The	  thermodynamics	  and	  kinetics	  of	  antigen	  binding	  under	  diffusive	  conditions	  
to	   an	   electrode	   surface	   modified	   with	   ferrocene-­‐tagged	   antibodies	   is	   studied	  
within	   this	  work,	   and	   realised	   experimentally	   for	   the	   case	   of	   human	   chorionic	  
gonadotropin	   (hGC)	   as	   the	   antigen	   with	   monoclonal	   anti-­‐hCG	   antibodies	  
immobilised	   on	   an	   electrode	   surface	   via	   a	   molecular	   wire	   platform.	   	   The	  
formation	  of	  the	  antigen-­‐antibody	  complex	  is	  monitored	  through	  the	  blocking	  of	  
the	   ferrocene	   voltammetry,	   thereby	   enabling	   the	   fractional	   coverage	   of	   the	  
electrode	  binding	  sites	  to	  be	  unravelled	  as	  a	  function	  of	  time.	  	  It	  is	  found	  that,	  at	  
low	   antigen	   concentrations,	   a	   Frumkin	   adsorption	   isotherm	   fits	   the	   data,	  with	  
repulsive	  interactions	  between	  bound	  antigens	  playing	  a	  significant	  rôle,	  with	  an	  
affinity	   constant	   that	   is	   two	   orders	   of	  magnitude	   larger	   than	   in	   the	   case	   of	   an	  
untagged	  antibody,	  suggesting	  that	  the	  chemical	  hydrophobicity	  of	  the	  redox	  tag	  
may	  encourage	  stronger	  binding.	  	  Comparison	  of	  the	  experimental	  temporal	  data	  
with	   relevant	   diffusion-­‐adsorption	   models	   under	   activation	   control	   allows	   for	  
the	  extraction	  of	  the	  kinetic	  parameters;	  	  at	  zero	  coverage,	  the	  rate	  constants	  for	  
adsorption	   and	   desorption	   are,	   respectively,	   larger	   and	   smaller	   than	   the	  
untagged	  antibody.	  	  The	  kinetic	  study	  enables	  the	  confirmation	  that	  this	  type	  of	  
platform	   may	   be	   utilised	   for	   rapid	   (15	   min)	   and	   quantitative	  
electroimmunoassay.	   	   This	   is	   validated	   through	   proof-­‐of-­‐concept	   analytical	  
measurements,	  yielding	  a	  limit	  of	  detection	  around	  25	  mIU	  mL-­‐1	  (corresponding	  
to	   2.7	   ng	  mL-­‐1)	   –	   a	   value	   used	   clinically	   for	   urine	   hCG	   measurements	  
corresponding	  to	  around	  four	  weeks	  of	  gestational	  age.	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Introduction	  
The	   hallmark	   of	   the	   specific	   adaptive	   immune	   response	   is	   the	   recognition	   of	  
antigens	  (often	  proteins	  or	  carbohydrates)	  through	  binding	  to	  immunoglobulins	  
(antibodies)	   present	   on	   the	   surface	   of	   B	   lymphocytes	   (B	   cells)	   [1,2].	   	   Such	  
protein-­‐protein	   binding,	   mediated	   by	   a	   mixture	   of	   electrostatic,	   hydrophobic,	  
hydrogen	  bonding	  or	  van	  der	  Waals’	  forces,	  occurs	  with	  a	  strong	  affinity	  constant	  
(108	  ±	  3	  M-­‐1),	  and,	  at	  least	  for	  the	  case	  of	  monoclonal	  antibodies,	  is	  highly	  specific,	  
so	  that	  the	  binding	  may	  discriminate	  between	  closely	  related	  compounds	  [3,4].	  
	  
The	   formation	   of	   such	   antibody-­‐antigen	   complexes	   has	   been	   exploited	  
extensively	   for	   the	   in	   vitro	  bioassay	   of	   a	   huge	   diversity	   of	   chemical	   structures	  
and	  organisms	  [1-­‐4],	  which	  has,	  inter	  alia,	  enabled	  a	  growth	  in	  analytical	  point-­‐
of-­‐care	  sensors	  detecting	  antigenic	  disease	  biomarkers	   [5].	   	   In	  general	   [6],	   two	  
classes	   of	   measurement	   are	   used	   by	   such	   sensors;	   	   in	   a	   first	   approach,	   the	  
binding	  assay	  uses	  an	  excess	  of	  the	  binding	  protein	  (antibody)	  that	  is	  conjugated	  
with	   a	   suitable	   chemical	   tag,	   affording	   a	   stoichiometric	   assay.	   	   Such	   systems	  
require	  separation	  of	  labelled	  and	  unlabelled	  antibody,	  typically	  through	  the	  use	  
of	  a	  solid	  support.	   	   In	  a	  second	  approach,	   the	  binding	  protein	   is	  kept	   in	   limited	  
amount,	   so	   that	   only	   a	   proportion	   of	   the	   antigen	   forms	   the	   antibody-­‐antigen	  
complex	  at	  equilibrium.	  	  In	  this	  scenario,	  initially	  bound,	  labelled,	  antigen	  may	  be	  
displaced	   from	   the	   binding	   equilibrium	   by	   free,	   unlabelled	   antigen,	   enabling	  
detection	  through	  the	  substoichiometric	  dilution	  principle	  [7].	  
	  
Immunoassay	   using	   electrochemical	   methods	   is	   highly	   popular,	   owing	   to	   the	  
ease	   through	   which	   developed	   sensing	   chemistry	   may	   be	   adapted	   to	   afford	  
portable,	   low	   cost	   and	   reliable	   “dipstick”	   sensors	   of	   high	   sensitivity	   [8],	  
especially	   for	   the	   case	   where	   the	   electrode	   surface	   itself	   is	   modified	   with	  
antibody;	   	   rapid	   quantitative	   assay	   then	   relies	   on	   the	   antigen	   concentration	   in	  
solution,	  the	  rate	  of	  antigen	  transport	  to	  the	  electrode	  surface	  and	  the	  kinetics	  of	  
the	   interaction.	   	   In	   a	   previous	   work	   [9],	   we	   employed	   ferrocene-­‐tagged	  
antibodies	  attached	  to	  an	  electrode	  surface	  through	  a	  molecular	  wire	  platform	  to	  
monitor	  the	  presence	  of	  biomarkers	  for	  cardiovascular	  disease	  in	  a	  physiological	  
Krebs-­‐Henseleit	   solution,	   where	   we	   demonstrated	   successful	   quantitative	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analysis	   using	   an	   antigen-­‐incubation	   time	   of	   20	   min.	   	   In	   this	   work,	   we	   are	  
interested	   in	   unravelling	   the	   physicochemical	   whys	   and	   wherefores	  
underpinning	   the	   chemoreception	   of	   that	   platform,	   to	   determine	   how	   low	   an	  
antigen	   incubation	   time	   is	   possible,	   whilst	   reliably	   providing	   quantitative	  
analysis.	   	   We	   use	   human	   chorionic	   gonadotropin	   (hCG)	   as	   the	   antigen,	   as	   the	  
clinical	  interest	  is	  of	  increasing	  hCG	  concentration	  [6],	  so	  that	  we	  may	  work	  with	  
known	   minimum	   biomarker	   levels	   (vide	   infra).	   	   This	   hormone	   is	   a	   37	  kDa	  
glycoprotein	   secreted	   by	   specialist	   syncytiotrophoblast	   cells	   of	   the	   developing	  
placenta	  following	  implantation	  of	  a	  corpus	  leteum	  [10,11].	  	  The	  presence	  of	  hCG	  
can	  be	  detected	  in	  serum	  and	  urine,	  in	  some	  cases	  as	  early	  as	  three	  to	  four	  days	  
following	  implantation,	  and	  therefore	  plays	  an	  important	  rôle	  in	  early	  pregnancy	  
diagnosis	  [12].	   	  However,	  the	  presence	  of	  hCG	  may	  indicate	  other	  health	  issues,	  
including	  ectopic	  pregnancy	  [13],	  choriocarcinoma	  and	  hydatidiform	  moles	  [14-­‐
16],	   thereby	   offering	   further	   clinical	   utility.	   	   The	   hormone	   comprises	   two	  
dissimilar,	  non-­‐covalently	  bound	  structures:	   	  the	  α	  and	  β	  subunits	  [11].	   	  The	  α-­‐
subunit	   is	   identical	   to	   those	   in	   the	   glycoprotein	   family,	   such	   as	   luteinizing	  
hormone,	   whereas	   the	   β-­‐subunit	   is	   unique	   to	   hCG	   and	   determines	   its	  
immunological	   properties,	   providing	   an	   ideal	   target	   for	   specific	   detection	   via	  
immunoassay	  techniques	  [10].	  
	  
The	   majority	   of	   hCG	   immunoassays	   most	   commonly	   use	   enzyme-­‐linked	  
immunosorbent	  assay	   (ELISA)	  and	  other	   sandwich	  assay	   techniques	   [17],	  with	  
recent	   advancements	   reported	   using	   chemiluminescence	   [18,19],	   fluorescence	  
[20],	  and	  electrochemical	  immunosensor	  approaches	  [21-­‐23],	  in	  addition	  to	  on-­‐
disc	  advancements	  [24].	  The	  diagnostic	  cut-­‐off	  for	  a	  positive	  reading	  is	  generally	  
25	  milliinternational	  units	  per	  millilitre	  (mIU	  mL-­‐1),	  corresponding	  to	  2.7	  ng	  mL-­‐
1,	  although	  this	  varies	  significantly	  from	  test	  to	  test	  [25].	  An	  hCG	  level	  of	  less	  than	  
5	  mIU	  mL-­‐1	  generally	  indicates	  a	  negative	  result	  [26].	  
	  
Previous	   work	   [27]	   has	   illustrated	   that	   for	   electrodes	   modified	   with	   anti-­‐hCG	  
immunoglobulins,	   the	  antibody	  orientation,	   in	   terms	  of	  binding	  site	  position,	   is	  
extremely	  important	  for	  maximising	  the	  sensitivity	  of	  an	  hCG	  sensor.	  	  Moreover,	  
neutron	  reflection	  studies	  have	  illustrated	  that	  for	  the	  ionic	  strengths	  employed	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in	  this	  work	  (typically	  ~200	  mM),	  hCG	  binding	  to	  IgG1	  mouse	  monoclonal	  anti-­‐β-­‐
hCG	  antibodies	  immobilised	  on	  silicon	  oxide	  wafers,	  is	  influenced	  by	  both	  steric	  
hindrance	   and	   electrostatic	   interaction	   between	   the	   antigen	   and	   the	   wafer	  
surface	   [28],	   and	   that	   decreasing	   the	   packing	   density	   of	   adsorbed	   antibody	  
increases	  the	  antigen	  binding	  capacity	  [29].	  It	  is	  clear	  that	  such	  steric	  crowding	  
and	  steric	  hindrance	  effects	  on	  binding	  arising	  from	  the	  adsorbed	  antibody	  may	  
be	   complemented	   by	   effects	   hitherto	   unreported	   pertaining	   to	   the	   mutual	  
repulsion	   that	   results	   from	   the	   binding	   of	   the	   antigen	   to	   the	   antibody.	   	   In	   this	  
paper,	  we	  examine	  the	  thesis	  that	  such	  antigen-­‐antigen	  repulsions	  on	  binding	  to	  
an	   antibody-­‐modified	   surface	   may	   be	   manifested	   through	   alterations	   in	   the	  
binding	   isotherm,	   which	   may	   be	   measured	   electrochemically,	   and	   which	   may	  
additionally	  affect	  the	  rate	  constants	  for	  hCG	  binding,	  and	  thence	  the	  capability	  
of	  this	  system	  in	  responding	  reliably	  for	  rapid	  immunoassay.	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Theory	  
Development	  of	  a	  Global	  Antigen	  Coverage	  Parameter	  
Our	   previous	   work	   on	   the	   development	   of	   a	   versatile	   platform	   for	  
electroimmunoassay	   [9],	   was	   exploited	   as	   the	   foundation	   for	   the	   method	  
described	  herein.	   	   In	  short,	  a	  redox-­‐labelled	  monoclonal	  antibody	  was	  attached	  
to	   an	   electrode	   surface	   through	   a	   covalently	   bound	   molecular	   wire,	   as	  
schematically	   illustrated	   in	  Figure	  1.	   	  The	  use	  of	  electrode-­‐grafting	  by	  reducing	  
diazonium	   functionalities	   means	   that	   a	   multilayer	   molecular	   wire	   platform	   is	  
present	   [30].	   	   In	   this	   work,	   we	   use	   the	   electrochemical	   reduction	   of	   a	  
nitrobenzene	  diazaonium	  salt.	  	  Accordingly,	  in	  order	  to	  form	  an	  amide	  link	  with	  
the	   antibody,	   the	   nitro-­‐moieties	   need	   to	   be	   completely	   reduced	   to	   the	   amine.	  	  
Owing	  to	  the	  complexity	  of	  this	  reduction	  [31],	  there	  is	  no	  easy	  way	  in	  which	  to	  
coulomb	  count	  this;	  	  we	  therefore	  assume	  the	  resulting	  surface	  is	  sprinkled	  with	  
nitro-­‐,	   nitroso-­‐,	   hydroxylamine	   and	   amine	   functionalities.	   	   This	   gives	   rise	   to	   a	  
platform	  that	  is	  chemically	  non-­‐uniform,	  and	  with	  a	  unique	  nanostructure.	   	  The	  
antibody	   is	   likewise	   randomly	   modified	   with	   the	   redox	   tag	   –	   typically	   this	   is	  
achieved	   through	   the	   formation	  of	   an	   amide	   linkage	  between	   the	   free	  primary	  
amine	  moieties	  on	  the	  antibody	  and	  an	  aldehyde	  or	  acid	  functional	  group	  on	  the	  
redox	   compound	   (such	   as	   ferrocenecarboxaldehyde	   or	   cis-­‐
bis(isothiocyanato)bis(2,2’-­‐bipyridyl-­‐4,4’-­‐dicarboxylato)ruthenium(II)).	   	   Whilst	  
there	   is	  an	  abundance	  of	   free	  primary	  amines	  at	  the	  paratopes	  of	  the	  antibody,	  
there	   is	  also	   the	  possibility	  of	   immobilising	   the	  redox	   functionality	  all	  over	   the	  
antibody.	   	   Furthermore,	   as	   indicated	   in	   Figure	   1,	   other	   than	   a	   statistical	  
likelihood	  of	  the	  free	  carboxylic	  acid	  on	  the	  labelled	  antibody	  combining	  with	  the	  
free	   amine	   groups	   on	   the	  modified	   electrode,	   there	   is	   a	   degree	   of	   uncertainty	  
within	   our	   antibody-­‐modified	   electrode	   system	   as	   to	   whether	   the	   antibody	   is	  
positioned	  correctly	  for	  antigen	  binding	  at	  the	  paratopes.	  
	  
The	   plethora	   of	   possibilities	   for	   non-­‐optimal	   signal	   generation	   in	   this	   system	  
means	   that	   the	   reliable	   and	   accurate	   sensing	   of	   antibody-­‐antigen	   binding	  
necessitates	   the	   use	   of	   a	   comparative	   approach	   (before	   and	   after	   exposure	   to	  
antigen),	  rather	  than	  an	  absolute	  approach	  (where	  the	  system	  chemistry	  is	  only	  
surveyed	   in	   the	   presence	   of	   a	   single	   concentration	   of	   antigen).	   	   Indeed,	   in	   our	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previous	   work	   [9],	   such	   antigen	   binding	   was	   inferred	   through	   the	   blocking	  
(current	   reduction)	   of	   the	   ferrocene	   signal.	   	   In	   this	   work,	   we	   build	   upon	   the	  
notions	   presented	   in	   our	   earlier	   work.	   	   However,	   we	   have	   been	   unable	   to	  
quantify	   (1)	   the	   number	   of	   redox	   labels	   per	   antibody,	   (2)	   the	   yield	   of	   the	  
antibody	   labelling	   process,	   and	   (3)	   the	   number	   of	   antibodies	   that	   are	  
immobilised	   on	   the	   electrode	   surface	   and	   their	   orientation.	   	  We	   therefore	   are	  
faced	   with	   the	   challenge	   of	   being	   unable	   to	   quantify	   the	   avidity	   of	   the	  
monoclonal	  antibodies	  used,	  which	  impacts	  on	  our	  predictive	  optimisation	  of	  the	  
electroimmunoassay.	  
	  
Accordingly,	   we	   introduce	   a	   global	   blocking	   fraction,	   θ,	   as	   a	   means	   to	  
parameterise	  the	  amount	  of	  antigen	  on	  the	  electrode	  surface	  (0	  ≤	  θ	  ≤1).	   	  This	  is	  
readily	   inferred	   from	   the	   kinetics	   of	   heterogeneous	   electron	   transfer	   in	   the	  
presence	  and	  absence	  of	  antigen,	  as	  discussed	  by	  Savéant	  [32],	  and	  Compton	  and	  
co-­‐workers	  [33]:	  	  for	  an	  electrode	  that	  engages	  in	  an	  electron	  transfer	  process	  in	  
the	  absence	  of	  any	  degree	  to	  which	  the	  redox	  process	  is	  blocked,	  with	  standard	  
heterogeneous	   rate	   constant	   (in	   a	   Butler-­‐Volmer	   framework)	   as	   k0,	   the	   rate	  
constant	   (ks)	   is	   lowered	   in	   the	  presence	  of	   a	  process	   that	   impedes	   this.	   	   	   Such	  
processes	  include	  partially	  blocking	  the	  active	  electrode	  area	  for	  a	  redox	  species	  
that	  relies	  on	  transport	  to	  the	  electrode	  surface	  [34],	  or	  burying	  the	  redox-­‐active	  
group	  within	   a	   self-­‐assembled	  monolayer	   so	   that	   the	   electron	   transfer	  kinetics	  
are	   limited	   by	   the	   degree	  with	  which	   the	   counter	   ions	  may	  move	   through	   the	  
structure	  [35].	  	  It	  is	  this	  latter	  pathway	  that	  is	  believed	  to	  be	  the	  method	  through	  
which	  the	  electroimmunoassay	  reported	  in	  our	  earlier	  work	  operates.	  	  Thus,	  to	  a	  
first	  order	  approximation,	  we	  may	  write	   the	   following	   for	   the	  rate	  constant	   for	  
electron	  transfer	  when	  antigen	  is	  bound	  to	  the	  antibody	  paratopes:	   .	  	  
It	   thus	   follows	   that,	   provided	   there	   is	   a	   route	   for	   the	   measurement	   of	   the	  
heterogeneous	   electron	   transfer	   rate	   constants,	   the	   degree	   of	   antigen	   binding	  
may	  be	  quantified	  through	  equation	  (1):	  
	   	   	   	   	   	   	   	   (1)	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This	   is	   a	   global	   antigen	   coverage	   parameter	   and	   is	   independent	   of	   the	   electrode	  
architecture;	   	   it	   merely	   depends	   on	   the	   antigen	   binding	   thermodynamics	   and	  
antigen-­‐antibody	   on/off	   kinetics.	   	   We	   next	   consider	   the	   affinity	   of	   the	   protein-­‐
protein	  interaction.	  
	  
Thermodynamics	  of	  Antigen-­‐Antibody	  Recognition	  
We	  consider	  the	  adsorption	  reaction	  between	  a	  freely	  diffusible	  antigen	  (AG)	  and	  
a	  surface-­‐immobilised	  receptor,	  such	  as	  a	  single	  paratope	  of	  an	  antibody	  (|-­‐AB):	  
	   	   	   	   	   (2)	  
Equality	  of	  the	  chemical	  potentials	  ( )	  of	  the	  antigen	  in	  both	  bulk	  solution	  and	  
in	  the	  adsorbed	  states	  occurs	  at	  equilibrium,	  
	   	   	   	   	   	   	   	   (3)	  
Thus,	   the	   change	   in	   standard	   Gibbs	   energy	   for	   the	   adsorption	   process,	  ΔG0ads,	  
may	   be	   expressed	   in	   terms	   of	   the	   activities	   (a)	   of	   the	   solution	   and	   adsorbed	  
antigen:	  
	   	   	   	   	   	   (4)	  
where	  R	  is	  the	  molar	  gas	  constant,	  T	  is	  the	  absolute	  temperature	  and	  Kads	  is	  the	  
equilibrium	   coefficient	   pertaining	   to	   the	   adsorption	   process.	   	   The	   adsorbed	  
antigen	   activity	   may	   be	   expressed	   through	   the	   fraction	   of	   the	   blocked	   (θ)	   to	  
unblocked	  (1-­‐θ)	  active	  paratopes	  on	  the	  surface-­‐confined	  antibody,	  yielding	  the	  
familiar	  Langmuir	  isotherm,	  on	  incorporating	  solution	  activity	  effects	  into	  Kads,	  to	  
afford	  the	  Langmuir	  isotherm	  constant	  Klang:	  
	   	   	   	   	   	   	   (5)	  
in	  which	  cbulkAG	  is	  the	  concentration	  of	  the	  antigen	  in	  bulk	  solution.	  
	  
The	  Langmuir	  isotherm	  neglects,	  amongst	  other	  things,	  the	  presence	  of	  nearest-­‐
neighbour	  interactions	  between	  adsorbed	  antigen	  molecules.	  	  The	  occurrence	  of	  
such	  attractive	  or	  repulsive	  lateral	  interactions	  would	  result	  in	  a	  modification	  of	  
the	  enthalpy	  change	  (ΔHads)	  associated	  with	  the	  adsorption	  equilibrium,	  and	  will	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depend	   on	   the	   fractional	   coverage.	   	   	   Thus,	   Taylor	   expansion	   of	   the	   standard	  
enthalpy	  change	  for	  adsorption	  affords,	  to	  a	  first-­‐order	  approximation:	  
	   	   	   	   (6)	  
where	   ΔGads	   and ΔSads	   respectively	   refer	   to	   the	   Gibbs	   energy	   change	   and	   the	  
entropy	   change	   that	   take	   place	   on	   adsorption	   of	   the	   antigen,	   and	   α	  
parameterizes	   the	   interactions:	   	   α	  <	  0	   corresponds	   to	   attractive	   interactions	  
within	  the	  adsorbed	  layer	  so	  that	  a	   larger	  amount	  of	  heat	   is	  generated	  through	  
successful	   adsorption;	   	   repulsive	   interactions	   are	   thus	   manifested	   through	   a	  
reduced	  amount	  of	  liberated	  thermal	  energy	  on	  adsorption	  as	  α	  >	  0.	  
	  
Thus,	   the	  effect	  of	  accounting	   for	   lateral	   interactions	   is	   to	  correct	   the	   isotherm	  
constant	  Klang	  with:	  
	   	   	   	   	   	   	   	   	   (7)	  
in	  which,	  
	   	   	   	   	   	   	   	   	   (8)	  
so	  that	  the	  parameter	  A	  is	  negative	  for	  repulsive	  lateral	  interactions	  and	  positive	  
attractive	   interactions	   as	   is	   negative.	   	   This	   gives	   rise	   to	   the	   Frumkin	  
isotherm	  [36],	  which	  will	  be	  employed	  within	  this	  work:	  
	   	   	   	   	   	   	   	   (9)	  
	  
It	   follows	   that	   a	   plot	   of	   	  against	  θ	   enables	   the	   determination	   of	  
both	   the	   affinity	   constant	  Klang	   and	   the	   extent	   of	   lateral	   interactions	   (A).	   	  Note	  
that	  since	  the	  adsorption	  process	  is	  exothermic	  (net	  bond	  forming),	  the	  constant	  
A	  is	  expected	  to	  be	  positive	  for	  attractive	  interactions	  and	  negative	  for	  repulsive	  
interactions.	  	  	  
	  
We	  next	  examine	  the	  kinetics	  of	  the	  bio-­‐recognition	  event.	  
	  
ΔHads = ΔHads
0 1−αθ( ) = ΔGads +TΔSads
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Rate	   Laws	   for	   the	   Formation	   of	   the	   Antibody-­‐Antigen	   Complex	   from	   Freely	  
Diffusible	  Antigen	  and	  Surface-­‐Confined	  Antibody	  
We	  consider	  the	  adsorption	  reaction	  between	  a	  freely	  diffusible	  antigen	  (AG)	  and	  
a	  surface-­‐immobilised	  receptor,	  such	  as	  a	  single	  paratope	  of	  an	  antibody	  (|-­‐AB):	  
	   	   	   	   	   (10)	  
The	   rate	   at	   which	   the	   surface	   concentration	   (Γ)	   of	   antibody	   and	   antibody-­‐
antigen	  complex	  changes	  via	  the	  heterogeneous	  adsorption	  kinetics	  balances	  the	  
rate	  of	  antigen	  transport	  through	  diffusion-­‐convection	  [37,38]:	  
	  
	  	   (11)	  
in	   which	   D	   is	   the	   apparent	   diffusion	   coefficient	   of	   the	   antigen,	   with	   the	  
concentrations	  of	  the	  antigen	  at	  the	  electrode	  surface	  and	  in	  bulk	  solution	  being	  
described	  through	  the	  use	  of	  the	  superscripts	  surf	  and	  bulk,	  respectively.	   	  Note	  
that	  although	  the	  experiments	  undertaken	  within	  this	  work	  (vide	  infra)	  are	  over	  
long	  timescales	  and	   in	  quiescent	  solution,	  diffusion	   is	  considered	  here	  as	  being	  
the	  major	  transport	  mechanism,	  since	  the	  natural	  convection	  that	  exists	  over	  this	  
timescale	  may	  be	  treated	  in	  terms	  of	  an	  effective	  diffusion	  coefficient	  [39].	  	  Thus,	  
δ	   is	   the	   diffusion	   layer	   thickness,	   and	   the	   ratio	   D/δ	   is	   the	   mass	   transport	  
coefficient.	  
	  
Mass	  balance	  on	  the	  electrode	  requires	  
	  	   	   	   	   	   (12)	  
where	  ΓTOT	   is	   the	   total	   surface	  concentration	  of	   the	  available	  paratopes.	   	  Using	  
this	  definition,	  it	  therefore	  does	  not	  matter	  that	  we	  consider	  the	  overall	  reaction	  
as	   being	   first	   order	   in	   antigen	   concentration,	   as	   we	   are	   not	   interested	   in	   the	  
reaction	  avidity	  (the	  number	  of	  antigens	  that	  bind	  to	  each	  antibody),	  but	  rather,	  
we	  are	  interested	  in	  the	  total	  number	  of	  available	  and	  active	  binding	  sites.	  	  In	  this	  
way,	   we	   are	   able	   to	   treat	   the	   system	   as	   tantamount	   to	   adsorption	   to	   form	   a	  




⎯ →⎯← ⎯⎯ |−AB : AG
dΓ |− AB:AG
dt
= k fΓ |− ABcAG
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through	   diazonium	   reduction,	   is	   more	   than	   likely	   to	   be	   multi-­‐layered	   (vide	  
supra).	  	  Hence,	  denoting	  the	  fraction	  of	  blocked	  binding	  sites	  as	  	  
	   	   	   	   	   	   	   	   (13)	  
equations	   (11)	   to	   (13)	   afford	   the	   following	   for	   the	   surface	   concentration	   of	  
antigen.	  
	   	   	   	   	   	   (14)	  
Thus,	  substitution	  into	  equation	  (11)	  yields:	  
	   	   	   	   	   	   (15)	  
In	   order	   to	   treat	   this	   particular	   problem	   in	   terms	   of	   general	   parameters,	  
following	   Savéant	   [37],	  we	   define	   the	   characteristic	   diffusion	   time	   in	   equation	  
(16)	  
	   	   	   	   	   	   	   	   (16)	  
and	  introduce	  the	  following	  dimensionless	  variables.	  
Normalised	  time:	  
	   	   	   	   	   	   	   	   	   (17)	  
Antibody-­‐Antigen	  Complexation:	  
	   	   	   	   	   	   	   	   (18)	  
Ratio	  of	  adsorption	  to	  transport	  rates:	  
	   	   	   	   	   	   	   (19)	  
Hence,	  from	  equations	  (9)	  and	  (18),	  the	  ratio	  of	  blocked-­‐to-­‐unblocked	  paratope	  
sites	  is	  given	  by	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It	   follows	   that	   the	   ratio	   of	   the	   forward	   to	   reverse	   rate	   constants	   is	   coverage-­‐
dependent,	  q.v.	  equation	  (21),	  
	   	   	   	   	   	   	   	   (21)	  
This	   means	   that	   one	   or	   both	   of	   kf	   and	   kb	   could	   be	   coverage-­‐dependent.	   	   For	  
simplicity,	   and	   in	   order	   to	   extract	   quantitative	   information	   from	   experimental	  
data,	  we	  adopt	  the	  arbitrary	  convention	  that	  the	  rate	  constant	  for	  the	  adsorption	  
process	   is	   coverage-­‐dependent,	   whilst	   the	   desorption	   rate	   constant	   is	  
independent	  of	  the	  coverage.	  	  Inasmuch	  as	  this	  is	  convenient,	  it	  can	  be	  partially	  
rationalised	   as	   follows.	   	   First,	   if	   the	   electrode	   surface	   is	   intrinsically	  
homogeneous	  and	  the	  concentration	  of	  antigen	  in	  the	  solution	  is	  fixed,	  the	  rate	  of	  
antigen	  binding	   is	  dependent	  on	  the	  heterogeneous	  collision	   frequency	  (Z),	   the	  
fraction	   of	   available	   binding	   sites	   (1-­‐θ),	   the	   fraction	   of	   antigen	  molecules	   that	  
possess	   the	  activation	  energy	   	   for	  binding,	  Ubind,	  given	  by	   the	  Boltzmann	   factor	  
,	  and	  the	  condensation	  coefficient	  (“sticking”	  probability,	  S*),	  which	  
is	   the	   fraction	   of	   moleculaes	   with	   energy	   U>Ubind	   that	   adsorb.	   	   Thus,	   we	  may	  
write	  the	  adsorption	  rate	  constant	  as	   .	   	  The	  rate	  constant	  
for	   the	   desorption	  will	   be	   affected	   by	   the	   fraction	   of	  molecules	   possessing	   the	  
activation	   energy	   for	   desorption	   (Ufree):	   ,	   where	   B	   is	   a	  
constant.	   	   Since	   the	   heat	   of	   interaction,	   ,	   is	   affected	   by	   the	  
occurrence	   of	   attractive	   and	   repulsive	   lateral	   interactions,	   the	   rate	   constant	  
ratio,	   ,	   would	   be	   independent	   of	   the	   antigen	   energy	  
unless	   the	   sticking	   probability	   (and	   therefore	   kf)	   in	   this	   formulation	   is	   more	  
greatly	   affected	   by	   the	   statistics	   of	   the	   neighbouring	   environment	   than	   the	  
constant	  B	  (and	  therefore	  kb).	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   (22)	  
and	  which	  requires	  solution	  subject	  to	  the	  boundary	  condition	  
	  
Note	   that	   this	   form	   of	   the	   rate	   law	   recognises	   that	   the	   extent	   of	   the	   lateral	  
interactions	  within	  the	  adsorbed	  layer	  changes	  with	  time.	  
	  
We	  first	  consider	  the	  case	  of	  the	  Langmuir	  isotherm	  (A	  =	  0),	  for	  which	  no	  lateral	  
interactions	  exist.	  	  This	  is	  the	  case	  that	  has	  been	  solved	  previously	  [37].	  	  In	  brief,	  
solution	   of	   the	   rate	   law	   proceeds	   through	   variable	   separation	   followed	   by	  
integration	  through	  substitution	  of	   ,	  to	  yield	  
	  	   	   	   	   (23)	  
This	   integrated	  rate	   law	  is	   for	  the	  general	  case,	  where	  activation	  and	  transport	  
both	  control	  the	  bio-­‐recognition	  process.	   	   	   If	   the	  rate	  constant	  for	  desorption	  is	  
tiny	   and/or	   the	   characteristic	   diffusion	   time	   is	   small,	   viz.	   ,	   so	   that	   the	  
desorption	   process	   is	   slow	   compared	   with	   the	   transport	   rate	   (irreversible	  
reaction),	   λ	  «	  κ.	   	   Furthermore,	   if	   the	   antigen	   concentration	   and/or	   the	  
Langmurian	   binding	   constant	   is	   large,	   ,	   equation	   (22)	   simplifies	   to	  
,	  which	  integrates	  to	  furnish	  equation	  (24).	  
	   	   	   	   	   	   (24)	  
Equation	  (24)	  comprises	  two	  terms	  in	  the	  fractional	  coverage,	  which	  correspond	  
to	   a	   linear	   dependence	   of	   coverage	   on	   antigen	   incubation	   time	   (for	   the	   larger	  
values	  of	  λ,	  corresponding	  to	  faster	  transport	  than	  adsorption	  in	  the	  chemically	  
irreversible	   binding	   scheme,	   equation	   (25))	   which	   relaxes	   to	   the	   logarithmic	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   (25)	  
	   	   	   	   	   	   	   	   (26)	  
We	  are	  interested	  in	  simplifying	  the	  rate	  law	  for	  the	  case	  that	  is	  likely	  to	  be	  most	  
relevant	   to	   the	   experimental	   work,	   viz.	   the	   antibody-­‐antigen	   binding	   is	  
irreversible,	   but	   with	   θ	  à	  0	   and	   λ	  «	  κ,	   so	   that	   the	   system	   is	   under	   activation	  
control.	  	  Thus,	  equation	  (23)	  affords	  equation	  (27):	  
	   	   	   	   	   	   (27)	  
It	   is	   relatively	   facile	   to	   test	   this	  equation	  with	   the	  experimental	  data,	   since	   the	  
equilibrium	  coverage	  of	  antigen	  is	  given	  by:	  
	   	   	   	   	   	   	   	   	   (28)	  
so	  that	  equation	  (27)	  may	  be	  recast	  as	  
	   	   	   	   	   (29)	  
Hence,	   a	   plot	   of	   	  against	   time	   enables	   the	   determination	   of	   the	  
forward	  rate	  constant,	  as	  this	  is	  the	  product	  Klangkb.	  	  
	  
The	   observation	   of	   non-­‐Langmuirian	   binding	   of	   labile	   antibodies	   to	   antigen-­‐
modified	  surfaces	  has	  been	  discussed	  within	  the	  literature	  [40].	  	  For	  the	  case	  of	  
the	   Frumkin	   isotherm	   considered	   in	   this	  work,	   A	  ≠	  0,	  we	   have	   been	   unable	   to	  
identify	  a	  method	  for	  the	  integration	  of	  the	  general	  case	  of	  the	  rate	  law,	  equation	  
(22).	   	   Nevertheless,	   the	   approximation	   that	   enables	   the	   rate	   law	   in	  
equation	  (22)	  to	  yield	  the	  following	  tractable	  form.	  
	   	   	   	   	   	   	   (30)	  
Since	   from	   equation	   (7),	   eAθ	   corresponds	   to	   the	   ratio	   of	   the	   Frumkin	   binding	  
constant	  (K,	  lateral	  interactions	  exist)	  to	  the	  Langmurian	  binding	  constant	  (Klang,	  
no	   lateral	   interactions	   exist),	   using	   equation	   (18),	   the	   approximation	   made	   is	  
θ ≈ τ
θ = 1− e−λτ












































1+ λeAθ 1−θ( )
	   15	  
that	   .	   	   For	   repulsive	   lateral	   interactions,	   A	   is	   negative,	   and	   this	  
approximation	   is	   only	   valid	   for	   small	   coverages	   (small	   antigen	   concentrations	  
and/or	  small	  incubation	  times);	   	  for	  attractive	  lateral	  interactions,	  A	  is	  positive,	  
and	  this	  approximation	  is	  only	  valid	  at	  large	  fractional	  coverage.	  	  Given	  that	  the	  
Frumkin	   binding	   constant	   is	   not	   normally	   known	   for	   any	   particular	   set	   of	  
experimental	   measurements,	   this	   approximation	   can	   be	   tested	   through	   its	  
estimation	  via	  the	  (generally	  known)	  Langmuir	  binding	  constant	  of	  the	  untagged	  
antibody.	  
	  
Integration	   of	   equation	   (30)	   proceeds	   through	   variable	   separation	   and	  
recognition	  of	  the	  validity	  of	  the	  power	  series	  expansion	  of	  ex,	  to	  afford	  
	   	   	   (31)	  
For	  the	  case	  when	  λ	  à	  0,	  corresponding	  to	  very	  slow	  desorption	  kinetics	  and/or	  
faster	  diffusion	  to	  the	  modified	  surface	  relative	  to	  surface	  reaction,	  equation	  (31)	  
may	   be	  written	   in	   the	   following	   form,	   from	  which	   kinetic	   information	  may	   be	  
extracted	  from	  experimental	  data.	  
	   	   	   (32)	  
The	   sum-­‐to-­‐infinity	   in	   the	   expression	   on	   the	   left-­‐hand	   side	   of	   equation	   (32)	  
converges	   rapidly,	   with	   i=200	   being	   more	   than	   sufficient	   to	   ensure	   complete	  
numerical	   convergence.	   	   Accordingly,	   rate	   constants	  may	   be	   extracted	   directly	  
from	   experimental	   data	   in	   the	   light	   of	   equation	   (32)	   through	   plotting	  
	  against	  time.	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Experimental	  
Chemical	  and	  Biochemical	  Reagents	  
Human	   chorionic	   gonadotropin	   (hCG)	   reactivity:	   human	   (100	   µg)	   and	   mouse	  
monoclonal	   anti-­‐hCG:	   reactivity	   human,	   500	   µg),	   were	   purchased	   from	  Abcam	  
(U.K.).	   	   The	   antigen,	   hCG	   was	   reconstituted	   to	   1	   mL	   with	   10	   mM	   phosphate	  
buffered	  saline	  solution	  (PBS)	  and	  stock	  solutions	  ranging	  1	  pg	  mL-­‐1	  to	  1	  µg	  mL-­‐1	  
were	  prepared	  with	  10	  mM	  PBS	  and	  20	  µL	  aliquots	  stored	  in	  the	  freezer	  until	  use.	  
4-­‐Nitrobenzene	   diazonium	   tetrafluoroborate	  was	   obtained	   from	   Sigma-­‐Aldrich	  
in	   the	   purest	   grade	   commercially	   available,	   and	   used	   as	   received.	  
Tetrabutylammonium	   perchlorate	   (TBAP),	   ferrocenecarboxaldehyde	   (FcCHO),	  
N,N-­‐dimethylformamide	   (DMF),	   sodium	   borohydride	   (NaBH4)	   and	   Tween	   20	  
were	  obtained	  from	  Sigma-­‐Aldrich.	  	  Water,	  with	  a	  resistivity	  of	  18.2	  MΩ	  cm,	  was	  
obtained	  from	  Milli-­‐Q	  Advantage	  A10	  Water	  Purification	  System	  (Millipore,	  U.K.).	  
Aqueous	   buffer	   solution	   was	   PBS	   at	   pH	   7.4,	   prepared	   by	   dissolving	   one	  
phosphate	   tablet	   (supplied	   from	   Sigma-­‐Aldrich)	   containing	   137	  mM	   NaCl,	  
2.7	  mM	   KCl	   and	   10	  mM	   phosphate	   in	   200	  mL	   deionised	   water.	   N-­‐
hydroxysulfosuccinimide	  (sulfo-­‐NHS,	  2	  mM)	  and	  N-­‐(3-­‐dimethylaminopropyl)-­‐N’-­‐
ethylcarbodiimide	   hydrochloride	   (EDC,	  5	  mM)	   were	   purchased	   from	   Sigma-­‐
Aldrich	   and	  both	   dissolved	   in	   10	  mM	  PBS	   immediately	   prior	   to	   use.	   	   All	   other	  
chemicals	  were	  purchased	  from	  Sigma-­‐Aldrich	  (U.K.)	  in	  the	  highest	  purity	  grade	  
commercially	  available	  and	  used	  without	  further	  purification.	  
	  
Instrumentation	  
Electrochemical	   studies	   were	   performed	   in	   a	   modified	   three-­‐electrode	   set-­‐up	  
with	  a	   tin-­‐doped	   indium	  oxide	   (ITO)	  coated	  glass	  working	  electrode	   (CB-­‐50IN-­‐
CUV,	   sheet	   resistance	   5-­‐15	   Ω,	   dimensions	   7	  x	  50	  x	  0.7	  mm,	   Delta	   Technologies	  
Ltd.,	  U.S.A.).	  A	  defined	  area	  was	  prepared	  with	  Fisherclark	  WS5002	  self	  adhesive	  
paper	   reinforcement	   rings	   (determined	   using	   a	   travelling	  microscope	   to	   be	   of	  
area	   0.28	   cm2),	   with	   one	   end	   used	   for	   electrical	   connection	   via	   application	   of	  
copper	  tape.	  Up	  to	  three	  individual	  electrode	  areas	  were	  prepared	  per	  electrode.	  	  
Owing	  to	  the	  increase	  in	  the	  electrode	  resistance	  with	  distance	  from	  the	  copper	  
tape	  connection,	   the	   location	  of	   the	  three	  working	  areas	  of	   the	  single	   ITO	  were	  
each	  precisely	  measured	  and	   the	   resistance	   from	  the	  copper	   tape	  connector	   to	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the	   centre	   of	   each	   area	   determined	   with	   a	   digital	   voltmeter.	   	   This	   was	  
undertaken	  so	  that	  in	  experiments	  where	  inter-­‐electrode	  comparisons	  needed	  to	  
be	  made,	  only	  those	  working	  areas	  that	  had	  the	  same	  electrode	  resistance	  were	  
used.	   	   It	  was	  observed	  that	  the	  area	  closest	  to	  the	  copper	  tape	  connector	  had	  a	  
resistance	   of	   0.37	  ±	  0.01	  kΩ;	   	   the	   next	   closest	   area	   had	   a	   resistance	   of	  
0.57	  ±	  0.01	  kΩ;	   	   the	   furthest	  away	  area	  had	  a	  resistance	  of	  0.82	  ±	  0.05	  kΩ.	   	  The	  
determined	  resistivity	  (measured	  as	  resistance	  multiplied	  by	  electrode	  area	  and	  
normalised	  by	   the	   straight-­‐line	   surface	  distance	   from	   the	   centre	   of	   the	   area	   to	  
the	   copper	   contact)	   was	   observed	   to	   be	   constant	   over	   the	   three	   areas,	   at	  
2.56	  ±	  0.08	  µΩ	  m.	  
	  
Electrochemical	  measurements	  were	  made	  in	  a	  30	  µL	  sample	  droplet	  with	  Pt	  or	  
nichrome	  wire	  as	  the	  counter	  electrode	  and	  a	  standard	  calomel	  electrode	  (SCE,	  3	  
M	  KCl)	  reference	  electrode	  (BAS,	  U.K.).	  All	  potentials	  are	  reported	  here	  against	  
this	  reference,	  unless	  otherwise	  stated.	   	  Measurements	  were	  controlled	  by	  a	  µ-­‐
AUTOLAB-­‐type-­‐III	   potentiostat.	   Cyclic	   voltammetry	   (CV)	   of	   the	   modified	  
electrodes	  was	  performed	  over	  variable	  scan	  rates	  between	  0.02	  V	  s-­‐1	  to	  1	  V	  s-­‐1.	  	  
The	   scan	   rates	   were	   varied	   in	   a	   randomised	   manner	   so	   as	   to	   guard	   against	  
electrode	  history	  effects.	   	  All	  electrochemical	  investigations	  were	  undertaken	  at	  
ambient	   temperature	   (293	  ±	  2	   K),	   in	   laboratory	   air	   of	   relative	   humidity	   in	   the	  
range	  50-­‐70%.	  
	  
ITO	  Surface	  Modification	  with	  Amine	  Groups	  	  
The	   working	   electrode	   employed	   for	   this	   study	   was	   made	   from	   ITO,	   because	  
these	  electrodes	  exhibited	  the	  most	  reproducible	  signals	  for	  this	  type	  of	  surface-­‐
based	   electrochemistry,	   compared	   with	   glassy	   carbon	   or	   polycrystalline	   gold.	  	  
ITO	   electrodes	   were	   cleaned	   prior	   to	   modification	   with	   isopropanol.	   Amine	  
modification	   of	   the	   electrode	   surface	   was	   achieved	   through	   electrochemical	  
reduction	  of	  2	  mM	  4-­‐nitrobenzene	  diazonium	  tetrafluoroborate	   in	  0.1	  M	  TBAP-­‐
MeCN	  for	  the	  period	  of	  four	  reduction-­‐oxidation	  cycles	  (+0.7	  V	  to	  -­‐0.4	  V)	  to	  yield	  
a	   nitrobenzene-­‐modified	   electrode,	   followed	   by	   six-­‐electron,	   six-­‐proton	  
reduction	  to	  afford	  the	  amine,	  aqueous	  ethanol	  containing	  0.1	  M	  KCl	  (10:90,	  v/v)	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from	  +0.4	  V	  to	  -­‐1.25	  V	  vs.	  SCE	  through	  four	  redox	  cycles,	   in	  a	  manner	  reported	  
previously	  for	  gold	  electrodes	  [9].	  
	  
Synthesis	  of	  Ferrocene-­‐Labelled	  Antibodies	  
Anti-­‐hCG	   antibodies	   were	   chemically	   labelled	   with	   ferrocene	   through	   the	  
coupling	   scheme	   reported	   previously	   [9]:	   	   10	   µL	   mouse	   monoclonal	   IgG	   was	  
diluted	   to	   200	   µL	  with	   10	  mM	  PBS	   (pH	   7.4)	   and	   the	   pH	   adjusted	   to	   pH~9	   by	  
addition	   of	   5	   wt.%	   potassium	   carbonate,	   with	   subsequent	   dilution	   with	   a	  
100	  mg	  mL-­‐1	   solution	   of	   ferrocene	   carboxaldehyde	   (FcCHO)	   in	   DMF,	   such	   that	  
the	   FcCHO	   was	   in	   excess.	   This	   was	   followed	   by	   incubation	   at	   ambient	  
temperature	   for	   30	  min	   to	   form	   the	   imine,	   subsequently	   reduced	  with	   sodium	  
borohydride	  (1.0	  mg),	  and	  incubated	  at	  ambient	  temperature	  for	  10	  min	  in	  order	  
to	  form	  the	  secondary	  amine	  (Scheme	  1).	  	  The	  solution	  was	  adjusted	  to	  pH	  ~7.3	  
using	   1.0	  M	   HCl.	   Excess	   tag	   and	   solvent	   were	   removed	   from	   the	   ferrocene-­‐
conjugated	   antibody	  product	   after	   reaction	  by	   centrifugation	   and	  washed	  with	  
10	  mM	  PBS	  (12	  krpm	  for	  20	  min,	  followed	  by	  twice	  washing	  with	  PBS	  at	  12	  krpm	  
for	  5	  mins,	  using	  Vivaspin	  500	  centrifugal	  filters	  purchased	  from	  GE	  Healthcare,	  
Sweden).	   Ultimately,	   400	   µL	   of	   the	   purified	   and	   concentrated	   ferrocene-­‐
conjugated	  antibody	  was	  obtained	  and	  stored	  within	  a	  refrigerator	  at	  277	  K	  until	  
immediately	  prior	  to	  use.	  	  
	  
Bio-­‐Conjugation	  of	  Ferrocene-­‐Labelled	  Antibodies	  to	  ITO	  Surface	  
The	   immobilisation	   of	   ferrocene-­‐tagged	   antibody	   on	   the	   electrode	   surface	  was	  
achieved	   through	   the	   coupling	  of	   carboxylic	   acid	  groups	  of	   the	  antibody	   to	   the	  
primary	  amine	  groups	  of	  the	  phenylamine-­‐modified	  ITO	  electrode	  surface	  via	  an	  
amide	   linkage,	   in	   a	   manner	   reported	   previously	   [9].	   	   The	   400	   µL	   aliquot	   of	  
ferrocene-­‐conjugated	   antibody	  was	  mixed	  with	   the	   same	   volume	   of	   activation	  
buffer	  (2	  mM	  EDC	  and	  5	  mM	  sulfo-­‐NHS	  in	  10	  mM	  PBS)	  for	  15	  min	  to	  activate	  the	  
carboxy	   terminal	   of	   the	   antibody.	   Subsequently,	   30	   µL	   of	   this	   solution	   was	  
applied	   to	   the	   amine	   functionalized	   ITO	   electrode	   and	   stored	   at	   277	   K	   for	   18	  
hours,	   after	  which	   the	  electrodes	  were	  washed	  with	  0.1	  vol.%	  Tween	  20	   in	  10	  
mM	  PBS,	   followed	  by	  PBS	   to	   remove	  unbound	  antibody,	  before	  drying	  under	  a	  
	   19	  
stream	  of	  nitrogen.	  The	  electrodes	  were	  used	   immediately,	  or	  stored	   in	  10	  mM	  




First,	  any	  non-­‐specific	  binding	  sites	  on	  the	  modified	  ITO	  surface	  were	  blocked	  by	  
the	   addition	   of	   20	   µL	   of	   1	   wt.	  %	   BSA-­‐10mM	   PBS,	   pH	   7.0	   for	   30	  min	   at	   room	  
temperature.	  Following	  this,	  the	  modified	  electrodes	  were	  rinsed	  with	  0.1	  vol.%	  
Tween	   20	   in	   10	  mM	  PBS	   followed	   by	   PBS.	   	   All	   electrodes	  were	   then	   tested	   in	  
physiological	   PBS	   using	   cyclic	   voltammetry	   for	   a	   series	   of	   ten	   scan	   cycles	   at	  
0.1	  V	  s-­‐1	  to	  ensure	  stability	  of	  the	  surface	  and	  of	  the	  corresponding	  signal.	   	  This	  
was	   followed	   by	   voltammetry	   at	   a	   variable	   scan	   rate	   (v)	   within	   the	   range	  
0.02	  ≤	  v/V	  s-­‐1	  ≤	  1.0,	   to	   obtain	   blank	   calibration	   data.	   After	   this,	   the	   antibody-­‐
modified	  electrodes	  were	   incubated	  in	  known	  concentrations	  of	  hCG	  antigen	  in	  
10	  mM	  PBS	  for	  particular	  time	  periods	  (15,	  30	  and	  60	  min)	  at	  room	  temperature.	  	  
Since	   the	   loss	   of	   pure	   bulk	   water	   to	   dry	   air	   occurs	   at	   an	   evaporation	   rate	   of	  
5.5	  µg	  s-­‐1	   at	   298	  K	   [41],	   the	   incubations	   with	   antigen	   were	   undertaken	   by	  
spreading	  antigen	  solution	  over	  the	  ITO	  slide.	  	  In	  this	  way,	  evaporation	  of	  water	  
from	   the	   exposed	   antigen	   solution,	   driven	   by	   the	   water	   vapour	   concentration	  
difference	   from	   0.58	   mM	   (at	   60%	   relative	   humidity)	   to	   0.96	   mM	   (at	   100%	  
relative	   humidity),	   would	   be	   sufficiently	   neglible.	   	   After	   incubation,	   the	  
electrodes	  were	  rinsed	  with	  Tween	  20	  and	  PBS,	  followed	  by	  drying	  in	  a	  nitrogen	  
stream,	  to	  remove	  any	  loosely	  bound	  antigen.	  	  The	  electrodes	  were	  then	  subject	  
to	   re-­‐examination	   by	   variable	   scan	   rate	   cyclic	   voltammetry	   in	   PBS,	   with	   scan	  
rates	  within	  the	  range	  0.02	  ≤	  v/V	  s-­‐1	  ≤	  1.0.	  	  	  
	  
Fitting	  of	  Experimental	  Data	  to	  Determine	  the	  Global	  Antigen	  Coverage	  Parameter	  
For	   a	   one-­‐electron	   process	   occurring	   within	   a	   surface	   monolayer,	   the	   current	  
that	   results	   from	  non-­‐interacting	   redox	   centres,	   is	   the	   summation	   of	   oxidation	  
and	  reduction	  processes:	  
	   	   	   	   	   	   	   (33)	  i = FS k
oxΓ red − k redΓox( )
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where	  i	  is	  the	  current,	  S	  the	  electrode	  area,	  F	  the	  Faraday	  constant	  and	  with	  rate	  
constants	   kj	   and	   surface	   concentrations	   Γj	   (j=ox	   or	   red),	   with	   the	   superscript	  
identifying	   the	  particular	   redox	   state.	   	  When	  electron	   transfer	   occurs	   from	   the	  
Fermi	  energy	  of	  the	  electrode,	  and	  the	  symmetry	  factor	  is	  close	  to	  ½,	  it	  has	  been	  
demonstrated	   that	   the	   Butler-­‐Volmer	   formulation	   for	   electrode	   kinetics	   is	  
adequate	   [35].	   	   This	   latter	   formulation	   of	   the	   electrode	   kinetics	   readily	  
empowers	   the	   determination	   of	   the	   standard	   heterogeneous	   rate	   constant	   for	  
oxidation	  of	  the	  immobilised	  ferrocenes	  (ks)	  to	  be	  extracted	  from	  the	  variation	  of	  
the	  peak	  oxidation	  potential	  with	  scan	  rate,	  since:	  
	   	   	   	   	   	   (34)	  
where	  F	   is	   the	  Faraday	  constant	   (96484.6	  C	  mol-­‐1),	  R	   is	   the	  molar	  gas	  constant	  
(8.3154	   J	  mol-­‐1	   K-­‐1),	   T	   is	   the	   absolute	   temperature	   and	   (E-­‐E0’)	   is	   the	   applied	  
overpotential.	  	  Accordingly,	  the	  experimental	  data	  were	  treated	  simplistically,	  so	  
that	  values	  of	  ks	  were	  extracted	   	   from	  the	  variation	  of	  peak	  potential	  with	  scan	  
rate	   upon	   solving	   equation	   (33)	   numerically	   under	   voltammetric	   conditions,	  
without	   considering	   any	  Ohmic	   loss.	   	   The	   variable	   scan	   rate	   data	   taken	   in	   the	  
absence	   of	   antigen	   enables	   the	   determination	   of	   k0,	   since	   antigen	   blocking	  
fraction	   (θ)	   is	   zero,	   and	   thus	  ks	  =	  k0.	   	  Thus,	   in	   the	  presence	  of	   the	  antigen,	   the	  
value	  of	  ks	  relates	  to	  the	  extracted	  value	  of	  k0	  through	   ,	  allowing	  the	  
global	  blocking	  fraction	  (θ)	  to	  be	  inferred	  at	  each	  incubation	  time	  via	  comparison	  
between	  blocked	  and	  unblocked	  electrode	  responses.	  
	  
It	   is	   important	   to	   realise	   that,	   since	   the	   experiments	  were	  undertaken	  with	  no	  
correction	   for	  Ohmic	   loss,	   the	   values	   of	   ks	   (and	  k0)	   estimated	  via	   this	   protocol	  
necessarily	   reflect	   contributions	   from	   both	   electrode	   kinetics	   and	  
electrode/solution	   resistances.	   	   Here,	   given	   that	   ferrocene	   redox	   tags	   were	  
employed,	  and	  that	  the	  solution	  resistance	  is	  constant	  between	  experiments,	  the	  
ITO	  electrode	  resistance	  is	  the	  largest	  source	  of	  error.	  	  This	  means	  that	  only	  those	  
working	   electrodes	   areas	   that	   held	   the	   same	   resistance	   could	   be	   compared	   in	  
kox = ks exp −
F
2RT





k red = ks exp
F
2RT





ks = k0 1−θ( )
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this	  manner.	   	  This	   is	   fully	  correct,	   since	  only	   those	  signals,	  which	  derived	   from	  
electrodes	   with	   similar	   resistances,	   were	   compared	   to	   obtain	   the	   results	  
reported	  herein.	  	  It	  also	  identifies	  that	  the	  values	  of	  k0	  and	  ks	  extracted	  from	  the	  
data	  are	  meaningless,	  unless	  directly	  compared.	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Results	  and	  Discussion	  
Figure	  2	  illustrates	  the	  voltammetry	  of	  anti-­‐hCG	  antibody-­‐modified	  electrodes	  in	  
PBS	  at	   a	   scan	   rate	  of	  0.1	  V	  s-­‐1,	   over	   ten	   consecutive	   cycles.	   	  As	   expected	   for	   an	  
electrode	  modified	  with	  soft	  matter	  [35,42,43],	  the	  first	  few	  cycles	  correspond	  to	  
“break-­‐in”	   scans,	   with	   significant	   capactative	   contributions	   owing	   to	   the	  
molecular	   rearrangements	   occurring	   so	   that	   counter	   ions	   to	   the	   immobilised,	  
electrogenerated	   ferricinium	   ions	   may	   find	   pathways	   through	   the	   protein	  
structure	  on	  the	  electrode	  surface.	  	  Consecutive	  cycling	  enables	  the	  voltammetric	  
waveshape	   to	   stabilise	   into	   the	  well-­‐defined	  waves	   at	   Emid	   =	  ½	   (EpOx	  +	  EpRed)	   =	  
0.22	   V	   vs.	   SCE,	   which	   correspond	   to	   the	   oxidation	   and	   re-­‐reduction	   of	   the	  
ferrocene	   labels	   covalently	   bound	   onto	   the	   ITO	   electrode.	   Increasing	   the	  
voltammetric	  scan	  rate	  results	  in	  larger	  separation	  between	  the	  peak	  potentials.	  	  
This	   is	  expected,	  since	   the	  heterogeneous	  rate	  constant	   for	   long-­‐range	  electron	  
transfer	  through	  a	  peptide	  chain	  is	  [44]	  0.2-­‐0.5	  s-­‐1	  for	  peptides	  comprising	  6-­‐11	  
amino	  acids;	  	  in	  larger	  nano-­‐objects,	  such	  as	  the	  antibody	  proteins,	  it	  is	  expected	  
that	   electron	   transfer	   rate	   constants	  would	   be	   considerably	   smaller.	   	   Figure	   3	  
illustrates	  typical	  data	  for	  the	  oxidation	  peak	  potential.	  	  The	  fitting	  of	  the	  trend	  in	  
these	  data	  with	  experimental	   timescale	  with	  those	  anticipated	  from	  the	  Butler-­‐
Volmer	   theory,	   by	   finding	   the	   minimum	   in	   the	   mean	   absolute	   error	   between	  
experiment	  and	  theory,	  enables	  the	  determination	  of	  the	  rate	  constant	  for	  the	  set	  
of	  data.	  
	  
In	   order	   to	   determine	   the	   global	   fractional	   antigen	   coverage,	   θ,	   the	  
heterogeneous	   electron	   transfer	   rate	   constant,	   ks	   is	   determined	   for	   both	   the	  
'blank'	  electrode	  (prior	   to	  antigen	   incubation)	  and	  post	   incubation,	  as	  required	  
by	  equation	  (1).	   	  By	  varying	  the	  timescale	  of	  the	  antigen	  incubation	  period,	  and	  
by	  varying	  the	  antigen	  concentration,	  both	  the	  thermodynamics	  and	  kinetics	  of	  
the	  antibody-­‐antigen	  binding	  event	  may	  be	  unravelled.	  	  Figure	  4	  shows	  the	  time-­‐
dependence	  of	  the	  blocking	  of	  the	  antibody-­‐modified	  electrode	  in	  the	  presence	  of	  
hCG	   of	   various	   concentrations.	   	   As	   expected,	   as	   the	   concentration	   of	   antigen	  
increases,	   the	   surface	   coverage	   also	   increases	   until	   a	   point	   of	   equilibrium,	   or	  
steady-­‐state,	  is	  reached.	  	  Langmurian	  plots	  of	  θ-­‐1	  against	   afforded	  highly	  
cAG
bulk( )−1
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curved	   plots	   of	   the	   form	   	  with	   Pearson’s	   product	  moment	  
correlation	   coefficient	   of	   0.925,	   and	   with	   greatest	   deviations	   at	   low	   antigen	  
concentrations.	   	   This	   is	   an	   indication	   of	   non-­‐Langmurian	   binding.	   	   Thus,	   at	  
equilibrium	   (t	   =	   60	  min),	   a	   plot	   of	   	  against	   θ,	   as	   suggested	   by	  
equation	   (9),	   and	   depicted	   in	   Figure	   5,	   enables	   the	   deduction	   of	   the	   affinity	  
constant,	   Klang	   =	   3.9	  ±	  0.8	  x	  1011	  M-­‐1.	   This	   is,	   in	   fact,	   two	   orders	   of	   magnitude	  
larger	  than	  that	  reported	  for	  the	  non-­‐redox	  tagged	  antibody	  [45],	  	  	  2.9	  x	  109	  M-­‐1,	  
suggesting	  that	  the	  presence	  of	  the	  hydrophobic	  redox	  tag	  empowers	  additional	  
interactions	  with	   the	   antigen,	   and	  which	   augers	  well	   for	   an	   analytical	   protocol	  
using	   this	  modified	   antibody.	   	   The	   gradient	   of	   the	  plot	   in	   Figure	  5	   enables	   the	  
deduction	   of	   the	   Frumkin	   isotherm	   parameter:	   	   A	   =	   -­‐14.4	  ±	  1.3.	   	   The	   negative	  
value	  of	  this	  is	  commensurate	  with	  repulsive	  interactions	  between	  chemisorbed	  
antigens,	  as	  expected	  for	  a	  surface	  where	  steric	  crowding	  may	  occur.	  
	  
In	   order	   to	   determine	   the	   effect	   of	   the	   larger	   affinity	   constant	   on	   the	   rate	  
constants	   for	   the	   adsorption	   and	   desorption	   of	   the	   antigen,	   experimental	   data	  
were	  treated	  through	  the	  plots	  suggested	  by	  equation	  (32).	  	  From	  the	  gradients	  
of	   these	   plots	   (not	   shown),	   the	   rate	   constant	   for	   antigen	   desorption	   was	  
identified	   as	   being	   essentially	   independent	   of	   the	   antigen	   concentration:	  	  
kb	  =	  6.5	  ±	  2.7	   x	  10-­‐5	  s-­‐1,	   enabling	   the	   rate	   constant	   for	   antigen	   adsorption	   to	   be	  
determined	   from	  equation	  (21):	   	  kf	  =	  2.2	  ±	  0.9	  x	  107exp(-­‐{14.4±	  1.3}θ)	  M-­‐1	  s-­‐1.	   	   It	  
is	  notable	  that	  these	  data	  are	  consistent	  with	  the	  increase	  in	  favourable	  binding	  
interactions;	   	   the	   rate	   constant	   for	   adsorption	   is,	   at	   zero	   coverage,	   an	  order	  of	  
magnitude	  larger	  than	  that	  of	  the	  untagged	  antibody,	  4.0	  x	  106	  M-­‐1	  s-­‐1	  [45],	  whilst	  
that	  for	  desorption	  is	  an	  order	  of	  magnitude	  smaller	  than	  that	  of	  the	  unlabelled	  
antibody,	   1.4	  x	  10-­‐4	  s-­‐1	   [45],	   suggesting	   that	   the	   hydrophobic	   redox	   tag	  
(ferrocene)	  may	  promote	  the	  binding	  process.	  
	  
In	  order	  to	  examine	  the	  closeness	  of	  fit	  between	  the	  experimental	  data	  and	  those	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equation	   (22)	   was	   simulated	   in	   Matlab	   (version	   R2013a)	   using	   the	   finite	  
difference	   method.	   	   	   In	   this	   case,	   first	   the	   parameter	   q	   (the	   characteristic	  
diffusion	   time)	   given	   by	   equation	   (16)	   was	   identified	   though	   a	   minimum	  
deviation	  between	  experiment	  and	  theory	  with	  its	  value	  being	  varied	  between	  1	  
and	  4000	  s,	  with	  a	  convergent	  data	  observed	   for	  a	   time	  node	  of	  10-­‐2	  s.	   	  Typical	  
values	  of	  q	  were	  between	  1-­‐48	  min	  (25	  min	  average),	  suggesting	  that	  above	  this	  
time,	  antigen	  transport	  to	  the	  surface	  may	  start	  to	  dominate	  the	  response.	  	  There	  
was	  no	  apparent	   correlation	  of	  q	  with	  hCG	  concentration,	   except	   that	   at	   lower	  
hCG	   concentrations	   q	   was	   towards	   the	   lower	   limit,	   and	   at	   higher	   hCG	  
concentrations	  q	  was	   towards	   the	  higher	   limit.	   	   Knowledge	  of	   the	   optimised	  q	  
values	   enabled	   the	   best-­‐fit	   data	   to	   be	   determined	   and	   contrasted	   with	   the	  
experimental	  points,	  as	  indicated	  in	  Figure	  6.	  	  It	  is	  readily	  seen	  that	  whilst	  the	  fits	  
are	  reasonable	  for	  lower	  concentrations	  of	  the	  antigen,	  the	  overall	  fit	  worsens	  at	  
higher	   antigen	   concentrations.	   	   Since	   rate	   constants	   were	   estimated	   from	  
activation	   approximations	   (equation	   (32)),	   and	   the	   solid	   lines	   fits	   in	   Figure	   6	  
determined	   through	   simulation	   of	   equation	   (22),	   which	   includes	   transport	  
processes,	   the	   poorer	   fit	   of	   the	   experimental	   transients	   at	   higher	   antigen	  
concentration	   corresponds	   to	   transport-­‐dominated	   processes	   at	   shorter	  
incubation	  times.	  	  This	  intuitive	  result	  nevertheless	  identifies	  that	  the	  protocols	  
developed	   may	   be	   exploited	   for	   bioanalytical	   measurement	   of	   antigen	  
concentration	  at	  short	  incubation	  times	  and	  for	  low	  antigen	  concentrations.	  
	  
In	   the	   light	   of	   these	  data,	   it	   follows	   that	   the	  use	  of	   low	  antigen	   concentrations	  
with	   short	   (~15	  min)	  modified	   electrode-­‐antigen	   incubations	   are	   sufficient	   for	  
this	   type	  of	  platform	   to	  be	  used	   for	   assessing	   the	  amount	  of	  hCG	  within	  a	  PBS	  
solution.	  	  Accordingly,	  in	  order	  to	  demonstrate	  a	  quantitative	  analytical	  protocol	  
of	  hCG,	  working	  curves	  for	  each	  respective	  incubation	  time	  were	  obtained	  for	  the	  
clinically	  relevant	  hCG	  concentration	  range	  within	  PBS	  solution.	  	  These	  comprise	  
plots	  of	  θ	  vs.	  lg([hCG]/ng	  mL-­‐1),	  and	  are	  illustrated	  in	  Figure	  7.	  	  	  Such	  curves	  are	  
linear	   with	   R2	   values	   greater	   than	   0.97	   (over	   three	   repeats),	   verifying	   that	   a	  
15	  min	   incubation	   time	   is	   suitable	   for	   rapid	   and	   quantitative	   analysis,	   with	  
excellent	   stability	   and	   inter-­‐experiment	   reproducibility.	   	   Limits	   of	   detection	  
(LoD)	  were	  determined	  (as	  three	  times	  the	  standard	  deviation	  normalised	  by	  the	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calibration	  graph	  gradient)	  to	  be	  20.2,	  28.3	  and	  19.8	  mIU	  mL-­‐1	  for	  the	  15,	  30	  and	  
60	  min	   incubation	   times,	   respectively,	   for	   hCG	   concentrations	   in	   the	   range	  
100	  pg	  mL-­‐1	  to	  1	  µg	  mL-­‐1.	  	  It	  is	  notable	  that	  the	  LoD	  for	  the	  15	  min	  incubation	  is	  
around	  the	  25	  mIU	  mL-­‐1	  cut-­‐off	  considered	  for	  pregnancy	  testing	  of	  urine	  hCG	  for	  





This	   work	   has	   considered	   the	   chemical	   biophysics	   underpinning	   an	  
electrochemical	  approach	  which	  monitors	  hGC	  binding	  to	  monoclonal	  antibodies	  
immobilised	  through	  a	  molecular	  wire-­‐type	  platform	  on	  an	  electrode	  surface.	  	  It	  
has	   been	   observed	   that	   the	   binding	   is	   chemically	   irreversible	   and	   non-­‐
Langmurian,	   as	   significant	   repulsive	   lateral	   interactions	   exist	   during	   the	  
chemoreception	  event.	  	  The	  kinetics	  of	  the	  binding,	  coupled	  with	  the	  larger	  value	  
of	  the	  Langmurian	  affinity	  constant	  in	  the	  redox-­‐tagged	  antibody	  compared	  with	  
the	  untagged	  literature	  data,	  suggest	  that	  the	  chemical	  nature	  of	  the	  redox	  tag	  on	  
the	  antibody	  (in	  this	  case,	  ferrocene)	  may	  actually	  enable	  slower	  dissociation	  of	  
the	   antibody-­‐antigen	   complex,	   with	   coverage-­‐dependent	   binding	   kinetics.	  	  
Through	   the	   comparison	  of	   experimental	  data	   treated	  under	  activation	   control	  
and	  non-­‐Langmuirian	  irreversible	  binding	  with	  a	  simulation	  of	  rate	  law	  under	  no	  
such	   assumptions,	   it	   has	   been	   observed	   that	   the	   approximations	   hold	   for	   low	  
concentrations	   of	   antigen,	   as	   expected,	   even	   for	   short	   antigen-­‐antibody	  
incubation	  times.	  	  This	  has	  been	  validated	  experimentally,	  and	  the	  potential	  use	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Figure	  Legends	  
Scheme	  1	  
Schematic	   illustration	  depicting	   the	   synthesis	   of	   the	   ferrocene	   tagged	  antibodies.	   	   In	  panel	   (a),	  
ferrocenecarboxyaldehyde	   is	   initially	  attached	   to	   the	  antibody	   through	  a	  Schiff	  base;	   	  panel	   (b)	  
identifies	   the	  conditions	   for	   the	  conversion	  of	   the	  Schiff	  base	   to	   form	  the	   ferrocene-­‐conjugated	  
antibody	  employed	  within	  this	  work.	  
	  
Figure	  1	  
Cartoon	   illustrating	   the	   nature	   of	   the	   electrochemical	   responses	   considered	   within	   this	  
manuscript.	   	   Although	   the	   electrode	   surface	   is	   shown	   as	   a	  monolayer	   in	   this	   illustration,	   it	   is	  
recognised	  that	  this	  is	  likely	  not	  the	  case	  (see	  text).	  
	  
Figure	  2	  
Cyclic	   voltammograms	   (0.1	   V	  s-­‐1)	   of	   the	   ferrocene-­‐tagged	   antibody	   immobilised	   on	   an	   ITO	  
electrode	  and	  immersed	  in	  10	  mM	  PBS	  at	  pH	  7.4.	  	  Ten	  scans	  are	  shown,	  testifying	  to	  the	  stability	  
of	  the	  modified	  electrode	  within	  this	  medium.	  
	  
Figure	  3	  
Extraction	  of	  the	  heterogeneous	  rate	  constants	  for	  the	  oxidation	  of	  the	  ferrocene	  redox	  tag	  from	  
variable	  scan	  rate	  cyclic	  voltammograms	  undertaken	  in	  10	  mM	  PBS	  at	  pH	  7.4.	  	  Experimental	  data	  
are	  illustrated	  as	  blue	  circles;	  	  the	  solid	  line	  corresponds	  to	  the	  expected	  behaviour	  under	  Butler-­‐
Volmer	  kinetics,	  with	  E	  representing	  the	  peak	  oxidative	  potential	  and	  v	  the	  voltammetric	  sweep	  
rate.	  	  The	  insert	  corresponds	  to	  the	  voltammograms	  analysed,	  with	  the	  legend	  affording	  the	  scan	  
rates	  in	  mV	  s-­‐1.	  	  In	  these	  experiments,	  the	  variable	  scan	  rate	  started	  from	  0.1	  V	  s-­‐1	  and	  varied	  in	  a	  
randomised	   fashion,	   returning	   to	   0.1	  V	  s-­‐1	   at	   the	   end,	   so	   as	   to	   encompass	   any	   effects	   due	   to	  
ferricinium	  ion	  instability	  within	  this	  medium.	  
	  
Figure	  4	  
Plots	  illustrating	  the	  global	  blocking	  coverage	  (θ)	  as	  a	  function	  of	  antigen-­‐incubation	  time	  in	  10	  
mM	  PBS	  at	  pH	  7.4,	  with	  varying	  concentrations	  of	  hGC	   in	   the	   range	  10-­‐1	  ≤	  [hCG]/ng	  mL-­‐1	  ≤	  103.	  	  
Key:	   	  The	   individual	  hCG	  concentrations	  are:	   	  100	  pg	  mL-­‐1	   (o),	  500	  pg	  mL-­‐1	   (x),	  1	  ng	  mL-­‐1	   (+),	  2	  




Typical	  analysis	  of	  the	  antigen-­‐antibody	  binding	  evolution	  for	  hCG	  under	  the	  Frumkin	  adsorption	  
isotherm	  equation	  (9).	  	  The	  data	  are	  shown	  for	  three	  incubation	  times:	  	  15	  min	  (blue	  diamonds),	  
30	  min	  (green	  triangles)	  and	  60	  min	  (red	  squares).	   	  Note	  that	  the	  extraction	  of	  thermodynamic	  
parameters	  is	  only	  valid	  for	  the	  data	  from	  60	  min	  as	  this	  corresponds	  to	  the	  point	  of	  equilibrium.	  
	  
Figure	  6	  
Comparison	  of	  experiment	  data	   (open	  points)	  with	   theory	   (solid	   lines)	   for	   the	  evolution	  of	   the	  
fractional	   coverage	   of	   the	   antibody-­‐modified	   electrode	   surface,	   during	   the	   course	   of	   antigen	  
incubation.	   	   Theoretical	   data	   were	   obtained	   through	   simulation	   of	   equation	   (22)	   using	   the	  
parameters:	   	   A	   =	   -­‐14.4	  ±	  1.3;	   Klang	   =	   3.9	  ±	  0.8	  x	  1011	  M-­‐1;	   kb	   =	   6.5	  ±	  2.7	  x	  105	  s-­‐1.	   	   The	   data	  
correspond	  to	  hCG	  concentrations	  of	  100	  pg	  mL-­‐1	  (blue	  lines	  and	  circles),	  500	  pg	  mL-­‐1	  (red	  lines	  
and	   circles),	   1	   ng	  mL-­‐1	   (black	   lines	   and	   circles),	   2	   ng	  mL-­‐1	   (green	   lines	   and	   circles),	   5	   ng	  mL-­‐1	  
(magenta	   lines	   and	   circles),	   10	  ng	  mL-­‐1	   (cyan	   lines	   and	   circles),	   20	  ng	  mL-­‐1	   (yellow	   lines	   and	  
circles),	  100	  ng	  mL-­‐1	  (red	  lines	  and	  squares)	  and	  1	  µg	  mL-­‐1	  (blue	  lines	  and	  squares).	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Figure	  7	  
Analytical	   calibration	   plot	   of	   fractional	   hCG	   coverage	   on	   the	   antibody-­‐modified	   electrode	  
extracted	  after	  hCG	  incubation	  times	  of	  15,	  30	  and	  60	  min	  periods	  in	  10	  mM	  PBS	  at	  pH	  7.4,	  with	  
hCG	  concentration.	  	  Lines	  of	  optimum	  fit	  are	  provided,	  for	  the	  data	  (averaged	  over	  three	  repeats).	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Figure	  7	  
	  
	  
	  
